NCT07793578
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07793578
Title Immunotherapy Plus Capivasertib for Metastatic Bladder Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors VA Office of Research and Development
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
VA Connecticut Healthcare System West Haven Campus, West Haven, CT West Haven Connecticut 06516-2770 United States Details
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA Boston Massachusetts 02130-4817 United States Details
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA Philadelphia Pennsylvania 19104-4551 United States Details
VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle Washington 98108-1532 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field